LinkedIn Profile

Access Xigen historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:xigen 761145 Jun 4th, 2019 12:00AM Xigen 175 6.00 Open Biotechnology Jun 4th, 2019 03:06PM Jun 4th, 2019 03:06PM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Open Open CH Health Care Equipment & Services
private:xigen 761145 Dec 16th, 2017 12:00AM Xigen 135 6.00 Open Biotechnology Dec 16th, 2017 02:21PM Dec 16th, 2017 02:21PM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Dec 17th, 2017 12:00AM Xigen 135 6.00 Open Biotechnology Dec 17th, 2017 08:12AM Dec 17th, 2017 08:12AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Dec 18th, 2017 12:00AM Xigen 135 6.00 Open Biotechnology Dec 18th, 2017 10:19AM Dec 18th, 2017 10:19AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Dec 19th, 2017 12:00AM Xigen 135 6.00 Open Biotechnology Dec 19th, 2017 05:03AM Dec 19th, 2017 05:03AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Dec 21st, 2017 12:00AM Xigen 135 6.00 Open Biotechnology Dec 21st, 2017 12:42PM Dec 21st, 2017 12:42PM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Dec 22nd, 2017 12:00AM Xigen 135 6.00 Open Biotechnology Dec 22nd, 2017 05:53AM Dec 22nd, 2017 05:53AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Dec 23rd, 2017 12:00AM Xigen 135 6.00 Open Biotechnology Dec 23rd, 2017 09:37AM Dec 23rd, 2017 09:37AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Dec 24th, 2017 12:00AM Xigen 135 6.00 Open Biotechnology Dec 24th, 2017 01:22PM Dec 24th, 2017 01:22PM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Dec 25th, 2017 12:00AM Xigen 135 6.00 Open Biotechnology Dec 25th, 2017 10:21AM Dec 25th, 2017 10:21AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.